Align Partners discloses 1.5% stake in SK, flags 75% valuation discount - report

Align Partners disclosed a 1.5% stake in SK Inc and said the conglomerate is undervalued, estimating intrinsic net asset value at about 100 trillion won—roughly 75% above the implied valuation. It cited SK’s 24.9 trillion won market capitalisation as of October 16 versus an approximately 60 trillion won value for its indirect SK hynix stake, and expects a corporate value-enhancement plan before year-end to help narrow the gap. SK was quoted at 478,000 won, up 11.68%; Align also estimates 2027 net income of about 24.4 trillion won, based on brokerage consensus estimates.

Analysis

The opportunity is a potential governance-driven rerating of SK Inc, not a new earnings signal for SK hynix (SKHY). The key second-order channel for SKHY is ownership: any credible simplification, distribution or monetization of the group’s holdings could change the parent-level claim on SK hynix value, but would not by itself improve SKHY’s operating outlook. Do not treat the two securities as interchangeable.

The 2027 net-income comparison is a weak valuation anchor until investors establish how much reflects recurring, cash-generative earnings attributable to SK Inc shareholders; reported profit can diverge materially from cash available for dividends or buybacks in a complex holding structure. Likewise, a stated NAV discount is not automatically recoverable: control complexity, capital-allocation uncertainty and taxes can sustain it.

Near term, the reported 11.68% share move raises the risk that catalyst optimism is already priced into SK Inc. Over the next 1–3 months, the decisive evidence is the actual value-enhancement plan: measurable distributions, buybacks/cancellations, asset-structure changes and implementation dates. Over 6–18 months, execution—not the announcement—would determine whether the discount closes. The thesis weakens if the plan is aspirational, earnings fail to convert to distributable cash, or SK Inc continues to retain value without a credible shareholder-return framework.

Key Decisions for Investors

• Avoid chasing SK Inc on the announcement narrative alone. Before taking exposure, verify the applicable listed instrument and establish whether the plan contains quantified, funded actions; the article does not specify the activist’s demands or proposed measures.
• Keep SKHY neutral as a direct expression of this catalyst. Reassess only if SK Inc’s plan creates a credible path to alter ownership, monetization or capital allocation around its SK hynix exposure; otherwise SKHY’s investment case remains primarily its own fundamentals.
• Watch for plan details and subsequent execution over the next 1–3 months: shareholder distributions, buyback/cancellation commitments, portfolio simplification and cash conversion. A plan without measurable amounts or deadlines is a thesis-negative signal, not a rerating catalyst.
• Treat the 2027 net-income estimate and NAV discount as claims to verify, not standalone valuation evidence. Check earnings attribution, recurring cash flow and cash actually available to shareholders; failure to demonstrate these would support a persistent holding-company discount.